|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/145 | |
| A61K 31/4402 | |||
| A61K 31/69 | |||
| A61K 39/395 | |||
| A61P 35/00 |
| (11) | Number of the document | 2704700 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12776352.2 |
| Date of filing the European patent application | 2012-04-27 | |
| (97) | Date of publication of the European application | 2014-03-12 |
| (45) | Date of publication and mention of the grant of the patent | 2018-06-27 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2012/035590 |
| Date | 2012-04-27 |
| (87) | Number | WO 2012/149419 |
| Date | 2012-11-01 |
| (30) | Number | Date | Country code |
| 201161480640 P | 2011-04-29 | US | |
| 201161556591 P | 2011-11-07 | US |
| (72) |
BERNAL-MIZRACHI, Leon, US
|
| (73) |
Emory University,
1599 Clifton Rd. 4th Floor, Atlanta, GA 30322,
US
|
| (54) | SELECTING USE OF PROTEASOME INHIBITORS BASED ON NF-KB2 SEQUENCE |
| SELECTING USE OF PROTEASOME INHIBITORS BASED ON NF-KB2 SEQUENCE |